The Sensydia Cardiac Performance System (CPS) enables the rapid assessment of critical care and heart failure patients by non-invasively measuring key hemodynamic metrics.
Location: United States, California, Los Angeles
Employees: 1-10
Total raised: $15.1M
Founded date: 2015
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.06.2023 | Grant | $3M | - |
| 09.05.2023 | - | $8M | Frontier O... |
| 17.08.2020 | Series C | $4.1M | - |
Mentions in press and media 15
| Date | Title | Description |
| 05.06.2023 | Sensydia Gets $3M In NIH Grant | Los Angeles-based Sensydia, a company working on non-invasive cardiac diagnostics, said this morning that it has received $3M in a NIH grant. According to the company, the funding came in the form of a Fast-Track Small Business grant from t... |
| 05.06.2023 | Sensydia Secures $3M NIH Grant | Sensydia, a Los Angeles, CA-based non-invasive cardiac diagnostic company, raised $3M NIH Grant. The Fast-Track Small Business grant came from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health ... |
| 05.06.2023 | Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform | - |
| 05.06.2023 | Biotech startup Sensydia secures $3M in NIH funding grant to revolutionize heart disease screening | Heart disease is the leading cause of death among people of all racial and ethnic groups in the United States. According to the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds in the United States from car... |
| 09.05.2023 | Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platform | - |
| 09.05.2023 | Sensydia Raises $8M In Funding | Sensydia, a Los Angeles, CA-based non-invasive cardiac assessment company, raised $8M in funding. The round was led by Orlando Health Ventures, with participation from Colle Capital, Frontier Venture Capital, and others. Concurrent with thi... |
| 08.02.2023 | Sensydia Achieves Study Target for Heart-Sound AI | Non-invasive cardiac assessment company Sensydia announced that it has completed its 225-subject development study at the University of Pittsburgh Medical Center (UPMC). This study was conducted at UPMC to collect data for its innovative AI... |
| 19.01.2022 | Sensydia wins FDA breakthrough nod to expand uses for its cardiac monitoring device | [Image from Sensydia]Sensydia announced today that it received FDA breakthrough device designation for its Cardiac Performance System (CPS). Los Angeles-based Sensydia designed CPS as a non-invasive cardiac monitoring device that reports cr... |
| - | Sensydia: Non-Invasive Cardiac Diagnostic Company Secures $3 Million NIH Grant | Sensydia – a non-invasive cardiac diagnostic company – announced recently that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Thi... |
| - | There’s No Real Plan for Preserving Internet Content. Here’s Why That’s a Problem | Back in April, image hosting site Imgur – a popular option for users of Reddit and similar forums seeking to post memes or photos – announced a sweeping change to its Terms of Service. As of May 15, the site will no longer host “nudity, por... |
Show more